Tasisulam sodium (LY573636 Sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study - Scagliotti, Giorgio V.; Eschbach, Corinna; Manegold, Christian (Journal of thoracic oncology, 2012)
Available online 20 November 2015